Skip to main content
Retour
Watch Compare

KALA BIO, Inc.

Qualité des données : 83%
KALA
Nasdaq Manufacturing Chemicals
0,18 €
▲ 0,00 € (2,64%)
Cap. Boursière: 166,32 M
Prix
0,18 €
Cap. Boursière
166,32 M
Fourchette du Jour
0,17 € — 0,19 €
Fourchette 52 Semaines
0,15 € — 20,60 €
Volume
1 454 736
Ouverture 0,18 €
Moyenne 50J / 200J
0,35 €
47,89% below
Moyenne 50J / 200J
3,77 €
95,16% below

Quick Summary

Points Clés

Negative free cash flow of -32,03 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-485,93%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,75
Interest Coverage-8,48

Valorisation

PE (TTM)
-4,64
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -4,6 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -35,84 M
ROE N/A ROA -117,37%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -32,03 M
ROIC -485,93% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,75
Interest Coverage -8,48 Asset Turnover N/A
Working Capital -8,30 M Tangible Book Value -8,67 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,64 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19,26%
Market Cap 166,32 M Enterprise Value 172,17 M
Per Share
EPS (Diluted TTM) -5,64 Revenue / Share N/A
FCF / Share -0,04 OCF / Share -0,04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89,38%
SBC-Adj. FCF -40,66 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -38,51 M -42,20 M -44,82 M -142,61 M -104,33 M
EPS (Diluted) -10,15 -17,35 -29,48 -2,19 —
Gross Profit — — — — —
Operating Income -40,98 M -39,66 M -81,71 M -130,25 M -96,23 M
EBITDA — — — — —
R&D Expenses — — — — 18,35 M
SG&A Expenses — 20,57 M 65,04 M 105,06 M 81,07 M
D&A 259 000,0 303 000,0 537 000,0 975 000,0 912 000,0
Interest Expense 5,78 M 5,81 M 7,27 M 8,38 M 8,59 M
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 55,48 M 55,95 M 86,82 M 139,43 M 221,61 M
Total Liabilities 43,15 M 48,45 M 67,85 M 122,62 M 121,61 M
Shareholders' Equity 12,33 M 7,50 M 18,97 M 16,80 M 100,00 M
Total Debt 20,10 M 34,19 M 43,30 M 80,00 M 75,00 M
Cash & Equivalents 51,18 M 50,90 M 70,50 M 92,14 M 77,26 M
Current Assets 52,80 M 52,87 M 85,94 M 124,37 M 171,38 M
Current Liabilities 16,96 M 8,35 M 25,69 M 37,42 M 22,23 M